CG Oncology (CGON) EBT Margin (2023 - 2026)
CG Oncology (CGON) reported EBT Margin of 5549.49% for Q1 2026, up 6071397.0% on a YoY basis from N/an in Q1 2025, and down 212.34% quarter-over-quarter from 1776.74% in Q4 2025.
CG Oncology (CGON) EBT Margin (2023 - 2026) Analysis & Trends
CG Oncology has reported EBT Margin for 4 years, with the latest figure at 5549.49% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 6071397.0% year-over-year to 5549.49%; the trailing twelve-month figure through Mar 2026 stood at 3677.52% (up 1227021.0% YoY), and the FY2025 full-year result was 3981.26%, up 374850.0% from the prior year.
- EBT Margin for Q1 2026 stood at 5549.49%, down from 1776.74% in the prior quarter.
- The five-year high for EBT Margin was 1776.74% in Q4 2025, with the low at 1655100.0% in Q4 2023.
- Historically, EBT Margin has averaged 176464.58% across 4 years, with a median of 6974.56% in 2024.
- Annual changes were most pronounced in 2024 — EBT Margin jumped 164812544 bps — and 2025, when it tumbled 6306403 bps.
- CG Oncology's EBT Margin stood at 1655100.0% in 2023, then surged by 100 bps to 6974.56% in 2024, then soared by 75 bps to 1776.74% in 2025, then slumped by 212 bps to 5549.49% in 2026.
- The last three EBT Margin figures came in at 5549.49% (Q1 2026), 1776.74% (Q4 2025), and 2623.53% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CG Oncology | 5.16 Bn | 5.16 Bn | -1.88 Mn | -5,549.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,549.49% |
| Dec 31, 2025 | -1,776.74% |
| Sep 30, 2025 | -2,623.53% |
| Mar 31, 2025 | -66,263.46% |
| Dec 31, 2024 | -6,974.56% |
| Sep 30, 2024 | -47,448.84% |
| Jun 30, 2024 | -17,036.04% |
| Mar 31, 2024 | -3,199.43% |
| Dec 31, 2023 | -1,655,100.00% |
| Sep 30, 2023 | -130,666.67% |
| Mar 31, 2023 | -4,471.65% |